Johnson & Johnson vs OptiNose, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Johnson & Johnson is the larger company by market value: $652.5 B against $135 M for OptiNose, Inc., 4833 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 5, 2024 for OptiNose, Inc.). OptiNose, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Johnson & Johnson had more revenue: $94.2 B in the year to December 2025 against $49 M for OptiNose, Inc. in the year to December 2020.
- Johnson & Johnson made a net profit of $26.8 B, while OptiNose, Inc. made a net loss of $100 M.
- Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against -203.1% for OptiNose, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Johnson & Johnson JNJ · #23 in the world | OptiNose, Inc. OPTN |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 1886 | 2010 |
| Size | ||
| Market cap | $652.5 B | $135 M* |
| Revenue | $94.2 B | $49 M |
| Net income | $26.8 B▲ best | $-100 M |
| Employees | 138,200 | — |
| Valuation | ||
| P/E ratio | 40.5× | — |
| Price to sales | 6.6× | — |
| Price to book | 8.0× | — |
| Free cash flow yield | 3.0% | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Oct 2026 | Market cap Jan 2024 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Johnson & Johnson or OptiNose, Inc.?
Johnson & Johnson is the larger company by market value: $652.5 B against $135 M for OptiNose, Inc., 4833 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 5, 2024 for OptiNose, Inc.). OptiNose, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, Johnson & Johnson or OptiNose, Inc.?
Johnson & Johnson had more revenue: $94.2 B in the year to December 2025 against $49 M for OptiNose, Inc. in the year to December 2020. Johnson & Johnson made a net profit of $26.8 B, while OptiNose, Inc. made a net loss of $100 M.
Which is more profitable, Johnson & Johnson or OptiNose, Inc.?
Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against -203.1% for OptiNose, Inc.
More about Johnson & Johnson
More about OptiNose, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.